Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response study of intrathecal ropivacaine during cesarean section with prophylactic metaraminol infusion
ChiCTR1800018053Phase 3Recruiting
- Sponsor
- Linping District Women and Children Care Hospital
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ropivacaine and metahydroxylamine in caesarean delivery (C-section) (5 arms), sponsored by Linping District Women and Children Care Hospital. Primary endpoint: Effective or ineffective anesthesia. Started Sep 2018; status: recruiting.
02
Drugs
ropivacainemetahydroxylamine
03
Conditions
caesarean delivery (C-section)
Beyond the preview
Go deeper on ChiCTR1800018053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018053.